Pablo J. Cagnoni, CEO and President at Rubius Therapeutics, Inc. (RUBY), sold 6,730 shares at $6.57 ($44K) on 2022-02-01, disclosed to the SEC on 2022-02-01.
Open-market sale of $44k RUBY by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| INCY | SELL | 2026-08-14 | $1.3M | — | Filing → |
| INCY | SELL | 2026-08-07 | $1.3M | — | Filing → |
| INCY | SELL | 2026-08-04 | $1.9M | — | Filing → |